Welcure Drugs Pharmaceuticals Ltd vs Yogi Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 26, 2026

Key Highlights

The Latest Trading Price of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0.18 as of 26 Oct 15:30 . The P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd is 0 as of March 2024 .The P/E Ratio of Yogi Ltd is 0 as of March 2024 . The Market Cap of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Yogi Ltd is ₹ 101.1 crore as of March 2024 . The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Yogi Ltd for the Jun '26 is ₹ 49.81 crore as compare to the Mar '26 revenue of ₹ 158.32 crore. This represent the decline of -68.54% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Yogi Ltd for the Jun '26 is ₹ 2.47 crore as compare to the Mar '26 ebitda of ₹ 7.99 crore. This represent the decline of -69.09% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Yogi Ltd changed from ₹ -0.16 crore to ₹ -1.62 crore over 9 quarters. This represents a CAGR of 179.80% The Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Yogi Ltd changed from 5.34 % on March 2026 to 5.34 % on March 2026 . This represents a CAGR of 0.00% over 1 years .

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

About Yogi Ltd

Yogi Limited was initially established in December, 1992 as Parsharti Investment Limited.
The name of the Company was changed from Parsharti Investment Limited to Yogi Limited on 16th June, 2022. The Company is primarily engaged in the business of real estate development, construction, contracting, building, town planning, infrastructure development, and estate development.
Its activities encompass a broad spectrum of projects including the planning, design, execution, and delivery of high-quality real estate and infrastructure assets.
The Company has undertaken and continues to undertake projects such as residential layout schemes, slum rehabilitation and redevelopment projects (SRA) in Mumbai, and other allied real estate development initiatives, which contribute significantly to urban growth and housing solutions.

FAQs for the comparison of Welcure Drugs & Pharmaceuticals Ltd and Yogi Ltd

Which company has a larger market capitalization, Welcure Drugs & Pharmaceuticals Ltd or Yogi Ltd?

Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr while Market cap of Yogi Ltd is 710 Cr

What are the key factors driving the stock performance of Welcure Drugs & Pharmaceuticals Ltd and Yogi Ltd?

The stock performance of Welcure Drugs & Pharmaceuticals Ltd and Yogi Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Welcure Drugs & Pharmaceuticals Ltd and Yogi Ltd?

As of October 26, 2026, the Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18. On the other hand, Yogi Ltd stock price is INR ₹157.9.

How do dividend payouts of Welcure Drugs & Pharmaceuticals Ltd and Yogi Ltd compare?

To compare the dividend payouts of Welcure Drugs & Pharmaceuticals Ltd and Yogi Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.